Seres Therapeutics Inc MCRB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/16/21 EDT
20.73UNCH (UNCH)
Volume
30,401
Close
20.73quote price arrow down-0.66 (-3.09%)
Volume
633,857
52 week range
3.41 - 38.50

...

Loading . . .
  • Open21.34
  • Day High21.34
  • Day Low20.16
  • Prev Close21.39
  • 52 Week High38.50
  • 52 Week High Date11/18/20
  • 52 Week Low3.41
  • 52 Week Low Date05/04/20

Key Stats

  • Market Cap1.898B
  • Shares Out91.55M
  • 10 Day Average Volume0.65M
  • Dividend-
  • Dividend Yield-
  • Beta3.96
  • YTD % Change-15.39

KEY STATS

  • Open21.34
  • Day High21.34
  • Day Low20.16
  • Prev Close21.39
  • 52 Week High38.50
  • 52 Week High Date11/18/20
  • 52 Week Low3.41
  • 52 Week Low Date05/04/20
  • Market Cap1.898B
  • Shares Out91.55M
  • 10 Day Average Volume0.65M
  • Dividend-
  • Dividend Yield-
  • Beta3.96
  • YTD % Change-15.39

RATIOS/PROFITABILITY

  • EPS (TTM)-1.13
  • P/E (TTM)-18.42
  • Fwd P/E (NTM)-14.74
  • EBITDA (MRQ)-81.552M
  • ROE (MRQ)-140.99%
  • Revenue (MRQ)33.22M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-268.33%
  • Debt To Equity (MRQ)14.36%

EVENTS

  • Earnings Date05/07/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Seres Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Seres Therapeutics, Inc. is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. The Company's drugs are designed to restore health by repairing the function of a dysbiotic microbiome. The Company is focused on implementing its microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109 is...
Stephen Berenson
Chairman
Eric Shaff
President
Marcus Chapman
Chief Financial Officer
David Ege Ph.D.
Executive Vice President
John Aunins Ph.D.
Executive Vice President
Address
200 Sidney St
Cambridge, MA
02139-4218
United States

Top Peers

SYMBOLLASTCHG%CHG
SRNE
Sorrento Therapeutics Inc
7.49+0.05+0.67%
MORF
Morphic Holding Inc
55.08-0.32-0.58%
BCRX
BioCryst Pharmaceuticals Inc
11.24-0.10-0.88%
RVNC
Revance Therapeutics Inc
27.22-0.94-3.34%
KURA
Kura Oncology Inc
28.59-0.88-2.99%